The patient recruitment and retention services market is projected to grow at an annualized rate of ~5%, till 2030
Roots Analysis has done a detailedstudy PatientRecruitment and Retention Services Marker, 2019-2030.”
, covering key aspectsof the industry’s evolution and identifying potential future growthopportunities.
To order this 300+page report, which features 90+ figures and 140+ tables, please visit this link
Key Market Insights
§ Presently, close to140 companies claim to be actively engaged in offering patient recruitment /retention services to the pharmaceutical and medical devices industries,employing a variety of outreach methods and solutions
§ The market landscapeis fragmented and distributed across various geographies; the growing need forspecialized / niche study populations and cost saving options have madeoffshoring a popular trend
§ Majority of theservices providers are based in developed regions; the market is characterizedby the presence of both established players and small-sized companies / newentrants
§ Companies involved inthis domain are steadily expanding their capabilities in order to enhance theirrespective service portfolios and comply to evolving industry benchmarks
§ The growing trend ofoutsourcing patient-recruitment-related activities is evident from the rise inpartnership activity in the recent past and from the opinions expressed byeminent stakeholders in the industry
§ Several growthopportunities, driven by increasing volume of clinical trials, exist; some ofthese focus specially on the development of therapies for rare and complexindications
§ We expect the patientrecruitment market for the services providers to increase steadily and grow byover 5% in the coming years
For more information, please visit https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market-2019-2030/245.html
Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. PATIENT RECRUITMENT AND RETENTION IN CLINICAL TRIALS
3.1. Chapter Overview
3.2. Clinical Trials
3.2.1. Clinical Trial Phases
3.3. Patient Recruitment
3.3.1. The Patient Recruitment Process
3.3.2. Challenges Associated withPatient Recruitment
3.3.3. Strategies to Improve PatientRecruitment
3.3.4. Ethical Considerations
3.4. Outsourcing of PatientRecruitment
3.4.1. Patient Recruitment Services
3.5. Patient Retention
3.5.1. Patient Retention Services
4. PATIENT OUTREACH METHODS
4.1. Chapter Overview
4.2. Patient Outreach Methods
4.2.1. Traditional Media
4.2.1.1. Physician Referrals
4.2.1.2. Television
4.2.1.3. Radio
4.2.1.4. Print Media (Newspaper, Flyers, Brochures and Posters)
4.2.1.5. Direct Mail Campaigns
4.2.1.6. Cold Call / Call Center
4.2.1.7. Advantages and Limitations of Traditional Media
4.2.2. Emerging / Novel Methods
4.2.2.1. Social Media
4.2.2.1.1. Social Media Platforms Used in Patient Recruitment
4.2.2.1.1.1. Geo-Social Media
4.2.2.1.1.2. Social Networking Websites
4.2.2.1.2. Advantages and Limitations of Social Media
4.2.2.2. Mobile / Software Applications
4.2.2.3. Patient Networks
4.2.2.4. Patient Advocacy Groups
4.2.2.5. Electronic Medical Records (EMRs) / Electronic Health Records (EHRs)and Other Health Data
4.2.2.6. Promotion of Trials in Indication Specific Events for Patients
4.2.3. Best Practices / Recommendationsfor Patient Outreach
5. COMPETITIVE MARKET LANDSCAPE OF PATIENT RECRUITMENT ANDRETENTION
SERVICE PROVIDERS
5.1. Chapter Overview
5.2. Patient Recruitment andRetention Service Providers: Overall Market Landscape
5.2.1. Analysis by Year ofEstablishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Geography
5.2.4. Analysis by Patient Recruitmentand Retention Services Offered
5.2.5. Analysis by Patient OutreachMethods
5.2.6. Analysis by Patient RecruitmentAssociated Services
5.2.7. Analysis by Patient RetentionMethods
5.2.8. Analysis by Geographical Reach
5.2.9. Analysis by TherapeuticExpertise
5.2.10. Information on Payment Model,Recruitment Technology / Platform, and Regulatory Approval /
Certification / Compliance Status
6. COMPANY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Methodology
6.3. Assumptions and Key Parameters
6.4. Patient Recruitment andRetention Service Providers: Company Competitiveness Analysis
6.4.1. Small-Sized Companies
6.4.2. Mid-Sized Companies
6.4.3. Large Companies
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Patient Recruitment Service Providers in NorthAmerica
7.2.1. Acurian
7.2.1.1. Company Overview
7.2.1.2. Financial Information
7.2.1.3. Patient Recruitment andRetention Services
7.2.1.4. Recent Developments
7.2.1.5. Future Outlook
7.2.2. BBK Worldwide
7.2.2.1. Company Overview
7.2.2.2. Financial Information
7.2.2.3. Patient Recruitment andRetention Services
7.2.2.4. Recent Developments
7.2.2.5. Future Outlook
7.2.3. Bright Pharmaceuticals Services
7.2.3.1. Company Overview
7.2.3.2. Patient Recruitment andRetention Services
7.2.3.3. Future Outlook
7.2.4. ClinEdge
7.2.4.1. Company Overview
7.2.4.2. Patient Recruitment andRetention Services
7.2.4.3. Recent Developments
7.2.4.4. Future Outlook
7.2.5. CSSi
7.2.5.1. Company Overview
7.2.5.2. Patient Recruitment andRetention Services
7.2.5.3. Recent Developments
7.2.5.4. Future Outlook
7.2.6. CTM
7.2.6.1. Company Overview
7.2.6.2. Patient Recruitment andRetention Services
7.2.6.2 Future Outlook
7.2.7. Integrated Clinical Trial Services (ICTS)
7.2.7.1. Company Overview
7.2.7.2. Patient Recruitment andRetention Services
7.2.7.3. Recent Developments
7.2.7.4. Future Outlook
7.2.8. MMG
7.2.8.1. Company Overview
7.2.8.2. Patient Recruitment andRetention Services
7.2.8.3. Future Outlook
7.2.9. Topstone Research
7.2.9.1. Company Overview
7.2.9.2. Patient Recruitment andRetention Services
7.2.9.3. Future Outlook
7.2.10. WCCT Global
7.2.10.1. Company Overview
7.2.10.2. Financial Information
7.2.10.3. Patient Recruitment Services
7.2.10.4. Recent Developments
7.2.10.5. Future Outlook
7.3. Patient Recruitment ServiceProviders in Europe
7.3.1. Antidote
7.3.1.1. Company Overview
7.3.1.2. Financial Information
7.3.1.3. Patient Recruitment and Retention Services
7.3.1.4. Recent Developments
7.3.1.5. Future Outlook
7.3.2. FIDELIS RESEARCH
7.3.2.1. Company Overview
7.3.2.2. Financial Information
7.3.2.3. Patient Recruitment and Retention Services
7.3.2.4. Recent Developments
7.3.2.5. Future Outlook
7.3.3. Ignite Data
7.3.3.1. Company Overview
7.3.3.2. Financial Information
7.3.3.3. Patient Recruitment and Retention Services
7.3.3.4. Future Outlook
7.3.4. Polaris BioPharma Consulting
7.3.4.1. Company Overview
7.3.4.2. Patient Recruitment and Retention Services
7.3.4.3. Recent Developments
7.3.5. Tudor Reilly Health
7.3.5.1. Company Overview
7.3.5.2. Financial Information
7.3.5.3. Patient Recruitment and Retention Services
7.3.5.4. Recent Developments
7.3.5.5. Future Outlook
7.4. Patient Recruitment ServicesProviders in Asia Pacific
7.4.1. CROèe
7.4.1.1. Company Overview
7.4.1.2. Patient Recruitment and Retention Services
7.4.1.3. Recent Developments
7.4.1.4. Future Outlook
7.4.2. Jsure Healthmedia
7.4.2.1. Company Overview
7.4.2.2. Patient Recruitment and Retention Services
7.4.2.3. Future Outlook
7.4.3. TrialWire
7.4.3.1. Company Overview
7.4.3.2. Patient Recruitment and Retention Services
7.4.3.3. Recent Developments
7.4.4. Pacific Groove
7.4.4.1. Company Overview
7.4.4.2. Patient Recruitment and Retention Services
7.4.4.3. Recent Developments
7.4.4.4. Future Outlook
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Patient Recruitment andRetention Services: List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnerships
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Purpose of Agreement
8.3.4. Analysis by Therapeutic Area
8.3.5. Most Active Players: Analysis byNumber of Partnerships
8.3.6. Geographical Analysis
8.3.6.1. Intercontinental andIntracontinental Agreements
9. RECENT TRENDS IN PATIENT RECRUITMENT AND RETENTION
9.1. Chapter Overview
9.1.1. Social Media-based Campaigningto Accelerate Patient Recruitment in Clinical Trials
9.1.2. Adoption of Mobile Technologiesfor Patient Recruitment and Retention
9.1.3. Use of EHR Data to ImprovePatient Recruitment Rates
9.1.4. Other Real-World Data Sources toHelp Overcome Patient Recruitment-Related Challenges
9.1.5. Growing Focus on ConductingClinical Research in Emerging Markets
10. FUTURE GROWTH OPPORTUNITIES
10.1. Chapter Overview
10.1.1. Anticipated Increase in the Numberof Global Clinical Trials
10.1.2. Growing Demand for Orphan Drugsand Personalized Medicine
10.1.3. Increased Offshoring of ClinicalDevelopment Operations to Emerging Regions
10.1.4. Availability of Service ProvidersOffering One-Stop-Solutions
10.1.5. Stringent Regulations and ComplexStudy Protocols Expected to Promote Outsourcing
11. MARKET SIZING AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Forecast Methodology and KeyAssumptions
11.3. Overall Patient RecruitmentServices Market, 2019-2030
11.4. Patient Recruitment ServicesMarket: Distribution by Therapeutic Area, 2019-2030
11.5. Patient Recruitment ServicesMarket: Distribution by Steps in Patient Recruitment Process, 2019-
2030
11.6. Patient Recruitment ServicesMarket: Distribution by Phase of Development, 2019-2030
11.7. Patient Recruitment ServicesMarket: Distribution by Geography, 2019-2030
11.7.1. Patient Recruitment ServicesMarket: Market Attractiveness Analysis by Country, 2019-2030
11.7.2. Patient Recruitment ServicesMarket in North America, 2019-2030
11.7.2.1. Patient Recruitment Services Market in the US: Distribution by Phaseof Development, 2019-
2030
11.7.2.2. Patient Recruitment Services Market in the US: Distribution byTherapeutic Area, 2019-2030
11.7.2.3. Patient Recruitment Services Market in Canada: Distribution by Phaseof Development, 2019-2030
11.7.2.4. Patient Recruitment Services Market in Canada: Distribution byTherapeutic Area, 2019-2030
11.7.3. Patient Recruitment ServicesMarket in EU5, 2019-2030
11.7.3.1. Patient Recruitment Services Market in Germany: Distribution by Phaseof Development, 2019-2030
11.7.3.2. Patient Recruitment Services Market in Germany: Distribution byTherapeutic Area, 2019-2030
11.7.3.3. Patient Recruitment Services Market in France: Distribution by Phaseof Development, 2019-2030
11.7.3.4. Patient Recruitment Services Market in France: Distribution byTherapeutic Area, 2019-2030
11.7.3.5. Patient Recruitment Services Market in the UK: Distribution by Phaseof Development, 2019-2030
11.7.3.6. Patient Recruitment Services Market in the UK: Distribution byTherapeutic Area, 2019-2030
11.7.3.7. Patient Recruitment Services Market in Italy: Distribution by Phaseof Development, 2019-2030
11.7.3.8. Patient Recruitment Services Market in Italy: Distribution byTherapeutic Area, 2019-2030
11.7.3.9. Patient Recruitment Services Market in Spain: Distribution by Phaseof Development, 2019-2030
11.7.3.10. Patient Recruitment Services Market in Spain: Distribution byTherapeutic Area, 2019-2030
11.7.4. Patient Recruitment ServicesMarket in Asia Pacific, 2019-2030
11.7.4.1. Patient Recruitment Services Market in Japan: Distribution by Phaseof Development, 2019-2030
11.7.4.2. Patient Recruitment Services Market in Japan: Distribution byTherapeutic Area, 2019-2030
11.7.4.3. Patient Recruitment Services Market in South Korea: Distribution byPhase of Development, 2019-2030
11.7.4.4. Patient Recruitment Services Market in South Korea: Distribution byTherapeutic Area, 2019-2030
11.7.4.5. Patient Recruitment Services Market in Australia: Distribution byPhase of Development, 2019-2030
11.7.4.6. Patient Recruitment Services Market in Australia: Distribution byTherapeutic Area, 2019-2030
11.7.4.7. Patient Recruitment Services Market in China: Distribution by Phaseof Development, 2019-2030
11.7.4.8. Patient Recruitment Services Market in China: Distribution byTherapeutic Area, 2019-2030
11.7.4.9. Patient Recruitment Services Market in India: Distribution by Phaseof Development, 2019-2030
11.7.4.10. Patient Recruitment Services Market in India: Distribution byTherapeutic Area, 2019-2030
11.7.5. Patient Recruitment ServicesMarket in Rest of the World, 2019-2030
11.7.5.1. Patient Recruitment Services Market in Rest of the World:Distribution by Phase of Development, 2019-2030
11.7.5.2. Patient Recruitment Services Market in Rest of the World:Distribution by Therapeutic Area, 2019-2030
12. CONCLUSION
12.1. Evolving Requirements Related toPatient Enrolment have Imposed a Significant Burden on Drug Developers, Causing Many to Outsource theirRecruitment and Retention-related Processes
12.2. Several CROs Offer PatientRecruitment and Retention Services across the Globe; North America and Europe have Emerged as Key Hubs
12.3. Currently, a Variety of OutreachMethods are being used to Enroll Patient from Across Different Geographies andTherapeutic Areas
12.4. Innovation, Use of Real WorldEvidence and the Establishment of Strategic Alliances between Stakeholders areAnticipated to Act as Key Market Enablers
12.5. Driven by the Increasing Demandfor Niche and Highly Specific Patient Populations in Clinical Trials, thePatient Recruitment Services Market is Anticipated to Witness SignificantGrowth in the Coming Decade
13. INTERVIEW TRANSCRIPTS
13.1. Chapter Overview
13.2. Link2Trials
13.2.1. Interview Transcript: Simon Klaasen,Co-founder and Managing Director
13.3. nRollmed
13.3.1. Interview Transcript: Hagit Nof,Chief Operation Officer and Business Development Officer
13.4. SeekerHealth
13.4.1. Interview Transcript: Paul Ivsin,Managing Director
14. APPENDIX 1: TABULATED DATA
15. APPENDIX 2: LIST OF COMPANIES ANDORGANIZATIONS
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
